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Objectives: to zdentzjiy clau&cants at hzgh rzsk (and low risk) of late vascular morb~&ty and mortahty after perzpheral 
bypass urgery. 
Design: prospecttve cohort study with mean follow-up of 8 6 years 
Patients: one-hundred and f~fty-f~ve claudicants elected for perzpheral bypass surgery. Only three patzents were lost to 
follow-up. End points were ma}or vascular events, ad&twnal znterventwns, all-cause mortahty, and functwnal outcome. 
Results: major vascular events occurred zn 59 patzents. Life-table analyszs revealed an annual risk zncrease of 3 5%. 
Strong predzctors were hypertenswn (hazard ratzo (HR) 2.7; 95% condidence zntervaI (CI) 1 5-4.8), dzabetes (HR 2 4, 
95% CI 1.0-5 4) and cardzac dzsease (HR 2.2, 95% CI 1.2-4.0) Sixty patients needed addztwnal interventzons w#h a 
hzghest mczdence (17%) m the f~rst year, and thereafter 2 8% each year None of the known rzsk factors were assoczated 
with an altered znczdence of mterventzons Approxzmately 3.5% of patients dzed per year compared wzth 2% per year zn 
the control group. Prominent hzgh-rzsk factors for mortality were cardzac dzsease (HR 3.3; 95% CI 1 8-6.0) and dzabetes 
(HR 3 O; 95% CI 1 5-7.1). 
Conclusion: major vascula, events and ad&twnal mterventzons are common and serwus in claudicants. However, zt zs 
possible to select Iow-rzsk patzents in wluch perzpheral bypass surgery zs just~ed 
Key Wo, ds: Intermzttent clau&catwn; Cardzovascular dzsease; Mortahty, Morbzd#y, InframguznaI bypass, Reoperatwn, 
Funct~onaI outcome. 
Introduction consistent, and often long-term Improvement in symp- 
toms resulting from bypass urgery in terms of exercise 
It is generally assumed that mtermittent claudication performance and community-based walking ability, s
caused by femoral atherosclerosls i a relative in- These benefits of surgery support a relaxation toward 
dlcation for peripheral bypass surgery, because the the indications for investigation and intervention of 
natural history of the disease is characterised by a low claudicants. 6'9 On the other hand, it is important o 
risk of limb-loss and a high risk of cardiovascular realise that claudicants elected for peripheral bypass 
death. 1'2 This assumption supports an initial con- surgery may require additional arterial interventions 
servative approach to most patients with intermittent for symptoms of recurrent limb lschaemla caused by 
claudlcation; structured exercise programs are valu- new occlusive lesions or late complications of the 
able, and modification of risk factors, especially ces- initial su~'gical reconstruction. Even more Important is 
sation of smoking, is widely advocated. 3'4Satisfactory the high risk of cardiovascular morbidity and mortality 
results by conservative treatment, however, can take caused by associated lschaemic heart disease. I°-13 In 
as long as a year, and complete relief of symptoms practice, however, not all patients with intermittent 
of leg ischaemia is rare. s'6 Nowadays, an increasing claudication face comparable long-term risk, and it 
number of patients do not accept the limitations in becomes increasingly Important o stratify patients by 
physical and social activity caused by intermittent relative risk of an adverse clinical outcome. 
claudlcation7 and surgical intervention is requested. To redefine the indications for surgery in patients 
The rationale to these requests relates to the immediate, with intermittent claudication we determined the long- 
term risk of mortality, major vascular events, and need 
* Please address all correspondence to I Dawson, Department of for additional interventions. In addition, this study 
Surgery, IJsselland Zlekenhuls, PO Box 690, 2900 AR Capelle aan 
de IJssel, The Netherlands assessed the changes in self-reported walking ability, 
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Table 1. Patient characteristics at the time of bypass urgery, patients (50/155, 32%) had one or  more  climcal 
Characterlshc No % markers of cardiac disease: 22 patients (22/155; 14%) 
had a history of previous myocardial infarction, 19 
Age, y (mean±s D) 58±10 patients (19/155; 12%) had symptoms of angina pec- 
Male gender 144 93 
Hypertension 45 29 toris, 21 pahents (21/155; 14%) were treated for con- 
Diabetes melhtus 18 12 gestive heart failure, and 22 patients (22/155; 14%) 
Smoking 149 96 required therapy for symptomatic ventricular arrhyth- 
Cardiac &sease 50 32 
Cerebrovascular &sease 8 5 mia. In addition, eight patients (8/155; 5%) had a 
Previous vascular surgery 62 4o history of symptomatic erebrovascular disease and 
62 patients (62/155; 40%) had undergone vascular 
surgery or angioplasty in cerebral, coronary, or peri- 
pheral arteries (Table 1). i.e. functional outcome, following bypass surgery. 
Finally, the impact of coexistant cardiac disease and Bypass surgery was performed using the reversed 
other prognostic factors on the occurrence of adverse greater saphenous vein in 112 patients (112/155; 72%), 
events was evaluated, and prosthetic grafts in the remaining 43 patients (43/ 
155; 28%). In 54 patients (54/155; 35%) the distal 
anastomosis was made to the arteries below the level 
of the knee. Patients routinely had follow-up ex- 
Material and Methods aminations at 1, 3, 6, and 12 months after the date of 
operation and thereafter yearly for the rest of their 
Study population hves. In addition, patients and their family doctors 
were instructed to report immediately any cardio- 
The vascular egistry in the Department of Surgery at vascular and/or cerebrovascular symptoms. The ex- 
Leiden University Hospital was examined to identify ammations during follow-up were directed not only 
patients with intermittent claudicahon treated with an to the evaluation of the vascular econstruction and 
mfrainguinal bypass. Since intermittent claudication the limb, but also to other cardiovascular events. Data 
is at most a relative indication for vascular re- were rarely missing for the hard end points of this 
construction, only 155 consecutive patients underwent study, since standard evaluation forms or vascular 
infrainguinal bypass urgery for disabling claudication worksheets were used prospectively to document any 
between 1958 and 1988. Especially in the last decade, vascular or cardiovascular event with date, severity 
these patients account for no more than 10% of patients and outcome of each event. Moreover, a very high 
undergoing peripheral bypass surgery in our in- patient comphance resulted in an almost complete and 
stitution. The deosion to offer surgery was not only long-term follow-up. Only three patients (3/155; 2%) 
based on the severity of claudication, but also on other were lost to follow-up due to emigration after 1, 2, 
factors such as age of the patient, risks of surgery, and 15 months. Mean follow-up period for the whole 
favourable anatomic location of lesions, and failure of study population was 8.6 years and ranged from 1 
conservative treatment. This conservative r gimen, of month to 28 years. All patients were treated lifelong 
at least 6 months' duration, consisted of risk factor with oral coumarin derivates after operation. The op- 
modification in an attempt to decrease cardiovascular timal therapeutic range of international normahsed 
morhidity and mortality; unsupervised exercise train- ratios aimed at in these patients was between 2.8 
ing to increase pain-free walking time; and finally and 4.8. Every effort was made to stop the patient's 
treatment with oral anticoagulants o reduce the in- smoking, to control diabetes, and to reduce high dia- 
cidenceofischaemicevents. Ninety-two patients (59%) stohc and systolic blood pressure as rigorously as 
had a walking distance of less than 100 m and were possible during follow-up. Emphasis on aggressive 
categorised as severe claudicators, and 63 patients cholesterol-lowering therapy was given only in the 
(41%) had a walking distance of 100-500 m and were last years of the study period. 
categorised as moderate claudicators. 
There were 144 men and 11 women, with a mean 
age of 58 years (range 27-79) at time of surgery (Table End points 
1). Hypertension was present in 45 patients (45/155; 
29%), and 18 patients (16/155; 12%) had &abetes The primary end point of this study was death from 
mellitus. Most patients were current or former cigarette any cause. Secondary end points were major vascular 
smokers (149/155; 96%). Coexistent vascular disease event, or additional vascular intervention after the 30- 
was common (Table 1). At time of the bypass 50 day postoperative p riod. A major vascular event was 
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Risk for major vascular events the composite nd pomt of cardiovascular death, non- 
fatal myocardial infarction, non-fata] cerebral stroke, ]~0] c19] [< [21 [-] [105] [v21 [aa] [181 [8] 
or coronary artery bypass surgery for ischaemic heart 75% - 71% 
disease. An additional vascular intervention was de- r 6a~ I 7 
fined as a surgical or radiological intervention over F" ~- f f  
hme for graft complications or deterioration of peri- 5o% - 41% I 38% j~ 
32% I 
pheral arterial disease. Functional results were ana- ~ 26~o r -Z -  
lysed by determining the walking capacity at any 25%~ ~2-~,,, p<0001 
time period after operation. The presence of lschaemic ~-F ~ - ~ - F  (A) 
symptoms in both extremities were included ir- 
respective of the side of the infrainguinal bypass. 0% I I I I 
Postoperatively, lschaemic symptoms were classified [E45] [17] [8] ]2Jr___ [-] 
1103 [753 [30] [19]  [4] into one of the five categories of increasing levels of 75% . . . .  j 
seventy - no symptoms, mild (walking distance more 54~ [ 649 
than 500 metres), moderate (walking &stance of 100- I ~-  
500 metres), and severe claudication (walking &stance 50% - 3s~ 39~ ~;  
of less than 100 metres) and critical limb ischaemia or 25% ~d3 
amputation. The effects of additional vascular in- 27~ ~--~-J 
terventions were included for all the calculahons. ~ JS - r -  P < 00Ol 
(B) 
O% I I I I 
0 5 10 15 20 
Statistical analysis Years after mframgumal bypass 
Fig. 1. Kaplan-Meler shmates ofthe risk for major vascular events, 
All data were systematically stored in a computerised accordmg to (A) car&ac disease, and (B) hypertension Numbers m 
vascular data base. The Kaplan-Meier method of life- brackets indicate number of patients till at risk in each group at 
the beglrmmg of each time period (A) Cardiac disease. (~) yes, 
table analysis was used to estimate patient survival (--) no (B) Hypertension (--)yes, (--)no 
and the cumulative risk of adverse vents after surgery 
as a function of t ime) 4 Patient survival was compared cardiovascular death (41/74; 55%). The cumulahve 
with the expected survival in the Dutch population risk for either one of these events to occur increased 
(1880-1995) adjusted for age and sex by use of the from 20% at 5 years to 71% at 20 years after surgery, 
data base of the Central Bureau for Statistics, The i.e., an annual risk increase of 3.5%. Claudlcants with 
Hague, The Netherlands. The log-rank test was used a hmtory of cardmc disease (Fig la), or hypertension 
to compare the risk of events with respect to the (Fig. lb )were  more likely to develop major vascular 
absence or presence of clinical variables. In a multi- events compared to claudicants without these co- 
variate approach the stepwise Cox proportional haz- morbiditms. Diabetes (p>0.2), smoking (p>0.5), and 
ards method was used to determine the independent previous vascular intervention (p>0.1) did not in- 
effect of potential risk factors on outcome) 5 The relative fluence the occurrence of major vascular events (Table 
importance of associations tudied is expressed as a 2). Multivariate analysis revealed cardiac disease (HR 
hazard ratio (HR) and 95% confidence interval (CI). 2.2; 95% CI 1.2-4.0; p<0.01), hypertension (HR 2.7; 95% 
Statmtical significance was defined as p<0 05. CI 1.5-4.8; p<0.002), and diabetes mellitus (HR 2.4; 
95% CI 1.0-5.4; p<0.05) as sigmficant and independent 
predictors associated with a 2-3 hmes greater isk of 
major vascular events. 
Resu l ts  
Major vascular events 
Addztmnal vascular intervention 
Major vascular events occurred in more than one-third 
of the patients (59/155; 38%) at a mean duration of 93 A surprisingly high number of additional vascular 
months (range 1-277 months, medzan 62 months), mterventions were required after peripheral bypass 
The 74 events observed were non-fatal myocardial surgery. Sixty patients (60/155; 39%)underwent  sur- 
infarction (16/74, 22%), non-fatal cerebral stroke (8/ glcal or radiological intervenhon for deteriorating isch- 
74; 11%), coronary bypass surgery (9/74; 12%), and aemia of the legs during long-term follow-up. The 
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Table 2. Effect of potential risk factors on the incidence of major vascular events 
(univariate analysis). 
p value* No Major vascular events (%) 
5y 10y 15y 20y 
All patients 155 20 31 45 71 
Hypertension 
No 0.0005 110 14 27 39 64 
Yes 45 38 54 70t - -  
Diabetes melhtus 
No 0 21 137 17 29 44 70 
Yes 18 38 48t - -  - -  
C~garette smoking 
No 0 72 6 20-t 20t - -  - -  
Yes 149 20 35 46 72 
Cardiac &sease 
No 0 0005 105 14 26 38 63 
Yes 50 32 41 71t - -  
Previous intervention 
No 0 18 93 17 29 40 68 
Yes 62 26 43 63 81t 
*Only those differences with p<0.05 are considered significant, fthe standard error of the 
estimated risk exceeds 10% at this point m time 
Table 3. Additional vascular interventions according to the ipsilateral and contralateral 
lower extremity. 
Ipsilateral Contralateral Total 
No (%) No (%) No. (%) 
Inframgumal bypass* 15 (18) 15 (33) 30 (23) 
Inframgumal non-bypasst 31 (37) 9 (20) 40 (31) 
Supramgumal proceduret 13 (16) 10 (22) 23 (18) 
Major amputahon$ 7 (8) 6 (13) 13 (10) 
Mmcellaneous§ 17 (20) 6 (13) 23 (18) 
Total 83 (100) 46 (100) 129 (100) 
*Primary or secondary mframgumal bypass graft, tmterposmon graft, angloplasty with and 
without patch graft, and thromboembolectomy, Slower extremity amputation at below-knee 
or above-knee, §lumbar sympathectomy, toe or metatarsal mputation, and graft hgahon or 
exc ls lon  
mean durat ion f rom the inihal bypass operat ion to the limb ischaemia. The need for addit ional vascular inter- 
first subsequent intervention at lpsilateral or contra- vent ion was 17% in the first year and increased 2.8% 
lateral side was 51 months  (range 1-250 months;  me- per year on average over the next 19 years (Fig. 
dlan 23 months).  Most patients needed the intervention 2). Hypertension,  cardiac disease, diabetes mellitus, 
within 2 years after the initial operat ion for clau- smoking and previous vascular intervention all failed 
dication. A total of 129 procedures was performed,  of to influence the need for addihonal  vascular surgery 
which the majority on patent peripheral  bypass grafts significantly. 
(Table 3). If mult iple procedures were per formed sim- 
ultaneously, only the procedure most  responsible or 
important  o the overall effect was included. The 30- 
day reoperative mortahty  was 2.3% (3/129) Thirteen Mortality 
l imbs in 11 pahents  (11/155; 7%) ult imately required 
below or above-knee amputat ion at a mean of 6.7 No  deaths occurred within 30 days after the operation. 
years f rom the bypass operation. Twenty-three per Dur ing fol low-up, 62 patients (62/155; 40%) died at a 
cent of the claudicants (36/155; 23%) needed vascular mean durat ion of 109 months  (range 2-336 months;  
surgery on the contralateral side to gain relief f rom median 78 months).  Myocardia l  infarction (29/62; 
Eur J Vasc Endovasc Surg Vol 16, October 1998 
296 I. Dawson et al. 
Risk for additional vascular interventions predictors of late mortality. Diabetic patients were 
three times as likely to die as non-diabetic patients [115] [68] [24] [12] [4] 
75% -- 72% (HR 3.0; 95% CI 1 5-7.1, p<0.002), and patients with 
69~, F---J--- cardiac disease had a more than three-fold increased 
49% , I risk of death than those without cardiac disease (HR 
50%- . ___ ;  ~ 3.3; 95% CI 1.8-6.0; p<0.0001). Subgroup analysis of 
aa~ '~ claudlcants without cardiac disease revealed a survival 
J similar to the expected survival of the control group 
25% -d.rr ~ matched for age and sex (Fig. 3a). Claudicants with 
/ overt cardiac disease had a worse survival compared 
0% I I I I with that of the control group (Fig. 3b). 
0 5 10 15 20 
Years after mframgumal bypass 
Fig. 2. Kaplan-Memr estimates of the risk for additional in- 
terventions for all patmnts. Numbers m brackets m&cate number functzonal outcome 
of patmnts tllI at risk m each group at the begmnmg ofeach time 
period (--)All patients. Changes in self-reported walking ability during fol- 
low-up is shown in Fig. 4. In the majority of patients 
47°),  stroke (8/62, 13%) and other vascular events (4/ successful function, i.e. enhancement of walking abil- 
62; 6%) accounted for a total of 66% of late death ity, was maintamed throughout the fol low-up period. 
causes. The remaining 21 patients died of malignancies This improvement  in quality of life was achieved 
(15/62; 24%), respiratory disease (3/62; 5%) and sepsis regardless the development of l imb ischaemia t ipsi- 
(3/62; 5%) The observed survival estimates for clau- lateral or contralateral side of the infraingumal bypass 
dicants selected for bypass surgery at 5, 10, 15, and graft. The results were better and could be maintained 
20 years fol low-up were 82%, 66%, 53% and 36%, at higher degree of success by reoperation for failure 
respectively. These survival rates are significantly or relapse of ischaemia. At 1 year of the bypass oper- 
poorer than the expected rates in the control group, ation 74% of the patients at risk were symptom-free 
In the univariate analysis of prognostic factors cardiac with full restoration of function. However,  the chance 
disease, diabetes, and hypertension at time of bypass of remaining free of symptoms declined steadily to 
surgery were associated with a worse survival (Table 67%, 61%, and 56% at 10, 15, and 20 years, respectively. 
4). Multivariate stepwise analysis identified cardiac In addition to these rates of functional success, some 
disease and diabetes as significant and independent of the patients with mild or moderate claudication 
Table 4. Effect of potential risk factors on patient survival (univariate analysis). 
p value* No Patient surwval (%) 
5y 10y 15y 20y 
All patients 155 82 66 55 36 
Hypertensmn 
No 0 05 110 85 68 61 42 
Yes 45 78 60 29t 19t 
Diabetes melhtus 
No 0 05 137 85 69 58 39 
Yes 18 69J- 31t - -  - -  
Cigarette smoking 
No 0 59 6 80q 80t 80t 80-L 
Yes 149 83 65 53 35 
Cardtac disease 
No 0 003 105 89 72 63 42 
Yes 50 68 54 27 13 
Previous intervention 
No 0 88 93 83 65 56 37 
Yes 62 84 67 45 30+ 
*Only those differences with p<0 05 are considered slgmficant 
~-The standard error of the estimated risk exceeds 10% at thts point m time 
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Patient survival Discussion 
100% ~ (A) The treatment of intermittent claudication has been 
~ ~ s 3 . ~ ~  the subject of considerable controversy over the years. 
75% 
8 ~  To some extent this can be explained by a lack of ~ % explicit objectives for treatment. Is the aim to save the 50% leg, improve quality of life or to prolong life, and 
~ ~ if so, in what way? Several authors have therefore 
25% P = NS emphasised the benign natural course of claudication 
with respect o limb loss 16-:8 while others have found 
0% I I I I surgical treatment warranted in view of superior func- 
tional results. 6'19 Controversy about the best method 
100% ~ ~ ' ~  of treatment could also be explained by uncertainty 
(B) about the long-term risks and complications after sur- 
75% ~". . . . . v l~  gery. The pr imary aim of the present study was to 
. obtain reliable information that surgeons need to dis- 
"--. 55~ cuss with patients when options for management  of 
50% - ~ 54~" ~ - - ~  -. ~7~ intermittent claudicatlon are under consideration. For 
this purpose we identified claudicants at high and low 
25% - ~2~7/ / / /~  risk of late major vascular events, additional vascular 
m ervon  on  and subsequent mor ai  y bypas  
0% , I y / / / / /~ / /~A surgery. 
0 5 10 15 20 
Our study, however, had several limltat~ons that Years after infrainguinal bypass 
deserve comment. First, data collection relied on ab- 
Fig. 3. Kaplan-Memr estimates of patmnt survival based on mor- straction of medical records that occasionally were 
tahty from all causes Control group matched for age and sex, and incomplete or lacked documentation. By the use of 
compared with (A) patmnts without eardmc dmease; (B) patmnts 
with overt cardiac &sease. Shadmg area re&cares the standard standard evaluation forms, however, data were rarely 
error Numbers m brackets indicate number of patmnts till at risk missing for the hard end points of this study. Second, 
m each group at the beglnnmg of each time period (A) ( ) Controls, as with all longitudinal studies, investigation and treat- 
( - )  claudlcants (n = 105) without cardmc disease, (B) ( ) controls, 
(--) claudlcants (n=50)wlthcardmc disease ment of patients with femoral atherosclerosis im- 
proved during this 30-year period, which may have 
influenced the findings of this investigation. Third, we 
had improved their preoperative walking distance concentrated on a selection of patients with in- 
durmg fol low-up and also benefited from surgery. The termittent claudication, i.e. those who had peripheral 
proport ion of patients with critical limb ischaemia or bypass surgery; hence, our results cannot be ex- 
a major amputat ion increased to 6% at 20 years, trapolated to all patients with penpheral  artenal 
100% ]1 [155] [103] [45] [28] [16 
75% 
50% 
25%' - -~  ~ !  
0% 
0 5 10 15 20 
Years after lnfraingumal bypass 
Fig. 4. Changes m self-reported walkmg ablhty following mframgumal bypass urgery for intermittent clau&catlon Numbers m brackets 
indicate number of patmnts till at rink in each group at the begmnmg ofeach time period ( . )  Critical hmb lschaemla or amputation; 
([]) severe laudlcatlon; ([]) moderate claudmatlon, ([]) mild claudlcation; ([~) no complamts 
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disease. Fourth, all patients were treated lifelong with For the low-risk subgroups of claudicants without 
oral anticoagulants, which may have influenced the comorbid conditions we suggest a low-threshold for 
incidence of long-term events, bypass surgery to rehef ischaemic symptoms of the 
Finally, spare emphasis was given to cholesterol lower extremities and improve the compromised life- 
lowering therapy since patients were followed from style. 
the late 1950s until the present ime, and support for 
aggressive cholesteroMowermg therapy as a com- 
ponent of secondary prevention ls provided by more 
recent clinical trials of statlns. 2°-22 Add#ional vascular intervention 
As expected, most additional interventions occurred 
in the first 2 years after bypass surgery, which is the 
Major vascular events period in which most vein graft stenoses are initially 
detected. 28"29 The mcreased occurrence of interventions 
As with all studies of intermittent claudlcatlon we in the first year is in agreement with studies examining 
have found a strong association with myocardial in- the incidence of late reoperation i vascular surgery. 29"3° 
farction and st roke .  12'13'23'24 Most patients experienced In addition, our data support he contention that re- 
this event withm 5-6 years, well within the average operation in vascular surgery is part of normal clinical 
follow-up of 8.6 years. Life-table analysis howed that practice. 29'31 Although it appeared that requirement for 
there was a cumulative risk of 3.5% each year during additional interventions per se did not adversely affect 
the 20 years of follow-up. Compared with patients the patients' perception of achieving a satisfactory 
treated for transient ischaemic attacks (TIA) of the result, 32 high-risk groups should be warned of the 
brain or eye this is a low risk rate. In a cohort of risks and consequences of reoperation. 29 The fact that 
hospital-referred patients an average risk of stroke, in our study none of the known risk factors were 
myocardial infarction or vascular death over the first associated with an altered incidence of intervention is 
5 years after TIA was 6.5% per year and the average difficult to explain, and may be the result of few 
risk of stroke, myocardial infarction or death from any numbers of patients. Nonetheless, the life-table curves 
cause was 7.5% per yearY With the use of multivariate show a non-significant trend to the detriment of 
techniques we found that patients with independent patients with diabetes, hypertension or previous vas- 
clinical markers of cardiac disease, hypertension and cular interventions. Others indicate diabetes, con- 
diabetes were associated with a two-three-fold greater tinued cigarette smoking 33 and a low initial ankle- 
risk for major vascular events. These findings compare brachial index 33 as strong predictors of disease pro- 
well with other s tud ies  12'13'23'24 and provide additional gression and subsequent vascular intervention. 34'35 
information to our previous reports regarding late 
cardiovascular events in patients elected for vascular 
surgery. ~1,26 
Data from the Prevention of Atherosclerotic Com- Mortality 
plications with Ketanserin study on patients with clau- 
dication showed that hypertension and diabetes were Our findings appear to be universal in patients with 
predictors of mortality and of non-fatal myocardial intermittent claudication. Many previous tudies have 
infarction and stroke. ~4 The importance of cardiac dis- reported an approximate doubling of the mortality 
ease and diabetes is underlined in two comparable rate among these patients 2,10,36-38 Mortality rates are 
studies examining the late cardiovascular morbidity further increased in patients with coexisting cardiac 
and mortality after lower extremity re- disease, 1'2'~2'38'39 diabetes, 2'12'a4'38 and advanced age, ~2'3g 
vascularisation ~2,~3 In both studies, the projected an- and in those who are smokers 39,40 This series, however, 
nual risk of a cardiac event was between 7-8%. This was so dominated by current or former smokers, that 
high incidence isexplained by the inclusion of patients demonstration f smoking as an independent predictor 
with critical limb ischaemia longside those with m- was not possible 
termittent claudication, although clearly the outcomes A major finding of this study was that the subgroup 
for such patients are markedly different. 2'26'a7 of patients without clinical evidence of cardiac disease 
Findings in the present study indicate that a lifelong appeared to have a normal life expectancy. This in- 
surveillance for systemic complications of athero- dicates that reconstructive surgery &d not adversely 
sclerosis is warranted, especially in the high-risk sub- affect patient survival, and probably improve quality 
groups with diabetes, hypertension rcardiac disease, of life. 
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